Characterizing how actinide properties change across the f-element series is critical for improving predictive capabilities and solving many nuclear problems facing our society. Unfortunately, it is difficult to make direct comparisons across the 5f-element series because so little is known about trans-plutonium elements. Results described herein help to address this issue through isolation of An(S2CNEt2)3(N2C12H8) (Am, Cm, and Cf). These findings included the first single crystal X-ray diffraction measurements of Cm–S (mean of 2.86 ± 0.04 Å) and Cf–S (mean of 2.84 ± 0.04 Å) bond distances. Furthermore, they highlight the potential of An(S2CNEt2)3(N2C12H8) for providing a test bed for comparative analyses of actinide versus lanthanide bonding interactions.
11 January 2016 in Journal of Low Temperature Physics
Increasing access to the short-lived α-emitting radionuclide astatine-211 (211At) has the potential to advance targeted α-therapeutic treatment of disease and to solve challenges facing the medical community. For example, there are numerous technical needs associated with advancing the use of 211At in targeted α-therapy, e.g., improving 211At chelates, developing more effective 211At targeting, and characterizing in vivo211At behavior. There is an insufficient understanding of astatine chemistry to support these efforts. The chemistry of astatine is one of the least developed of all elements on the periodic table, owing to its limited supply and short half-life. Increasing access to 211At could help address these issues and advance understanding of 211At chemistry in general. We contribute here an extraction chromatographic processing method that simplifies 211At production in terms of purification. It utilizes the commercially available Pre-Filter resin to rapidly (<1.5 h) isolate 211At from irradiated bismuth targets (Bi decontamination factors ≥876 000), in reasonable yield (68–55%) and in a form that is compatible for subsequent in vivo study. We are excited about the potential of this procedure to address 211At supply and processing/purification problems.
The rare earth isotope 163Ho is of interest for neutrino mass measurements. This report describes the isolation of 163Ho from a proton-irradiated dysprosium target and its purification. A Dy metal target was irradiated with 16 MeV protons for 10 h. After target dissolution, 163Ho was separated from the bulk Dy via cation-exchange high performance liquid chromatography using 70 mmol dm–3α-hydroxyisobutyric acid as the mobile phase. Subsequent purification of the collected Ho fraction was performed to remove the α-hydroxyisobutyrate chelating agent and to concentrate the Ho in a low ionic strength aqueous matrix. The final solution was characterized by MC-ICP-MS to determine the 163Ho/165Ho ratio, 163Ho and the residual Dy content. The HPLC purification process resulted in a decontamination factor 1.4E5 for Dy. The isolated Ho fraction contained 24.8 ± 1.3 ng of 163Ho corresponding to holmium recovery of 72 ± 3%.
About Me
Scientist, senior radiochemist with Isotope Production Team at Los Alamos National Laboratory
Scientist, senior radiochemist with Isotope Production Team at Los Alamos National Laboratory